The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse.
- 1 June 1978
- journal article
- Vol. 3, 237-41
Abstract
The clinical use of misonidazole as a hypoxic cell radiosensitizer is at present limited by its neurotoxicity at high doses (Urtasun et al., 1977; Dische et al., 1977). An in vivo neurological end point, viz. measurement of nerve conduction velocity, has been developed to examine sensitizer action. Conduction velocity in mice was measured as a function of time after a single dose of misonidazole and as a function of drug dose. Doses greater than 0.33 mg/g produced significant transient reductions in velocity. The time course of the reduction in velocity closely followed the uptake/excretion profile of misonidazole from blood serum.This publication has 6 references indexed in Scilit:
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- Clinical Phase I Study of the Hypoxic Cell Radiosensitizer RO-07-0582, A 2-Nitroimidazole DerivativeRadiology, 1977
- Mammalian cell toxicity of nitro compounds: Dependence upon reduction potentiaklBiochemical and Biophysical Research Communications, 1976
- Electron-Affinic Sensitization: VII. A Correlation between Structures, One-Electron Reduction Potentials, and Efficiencies of Nitroimidazoles as Hypoxic Cell RadiosensitizersRadiation Research, 1976
- Metronidazole neuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- Electrodiagnostic study of a patient with peripheral neuropathy after nitrofurantoin therapy.1967